Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 30, 2018
Current assets:
Cash and cash equivalents	$ 29,273	$ 33,258
Accounts receivable, net	80,748	78,118
Notes receivable, net	5,983	5,498
Income tax receivable	5,431	16,146
Inventories	26,144	27,203
Prepaid expenses	22,488	30,376
Other current assets	18,582	5,678
Assets held for sale	10,765
Total current assets	199,414	196,277
Property and equipment, net	217,437	226,894
Right-of-use assets	150,216
Notes receivable, less current portion, net	23,607	23,259
Goodwill	83,193	84,516
Deferred income taxes, net	1,244	1,137
Other assets	63,957	63,814
Total assets	739,068	595,897
Current liabilities:
Accounts payable	35,214	27,106
Income and other taxes payable	7,336	6,590
Accrued expenses and other current liabilities	120,975	129,167
Deferred revenue current	2,516	2,598
Current lease liabilities	22,546
Current portion of long-term debt	29,982	20,009
Total current liabilities	218,569	185,470
Deferred revenue	18,562	20,674
Long-term lease liabilities	130,391
Long-term debt, less current portion, net	346,433	601,126
Deferred income taxes, net	5,835	7,852
Other long-term liabilities	75,887	79,324
Total liabilities	795,677	894,446
Series B Convertible Preferred Stock; $0.01 par value; 260,000 shares authorized, 252,530 shares issued and outstanding at March 31, 2019; no shares issued at December 30, 2018	251,303
Redeemable noncontrolling interests	5,346	5,464
Stockholders’ (deficit):
Common stock ($0.01 par value per share; issued 44,303 at March 31, 2019 and 44,301 at December 30, 2018)	443	443
Additional paid-in capital	193,243	192,984
Accumulated other comprehensive (loss)	(4,846)	(3,143)
Retained earnings	231,439	242,182
Treasury stock (12,883 shares at March 31, 2019 and 12,929 shares at December 30, 2018, at cost)	(748,995)	(751,704)
Total stockholders’ (deficit)	(328,716)	(319,238)
Noncontrolling interests in subsidiaries	15,458	15,225
Total stockholders’ (deficit)	(313,258)	(304,013)
Total liabilities, redeemable noncontrolling interests, Series B preferred stock and stockholders’ (deficit)	$ 739,068	$ 595,897